… is involved in advanced lung cancer, the … disease progression. We found that D-dimer
levels dropped in responders (73.7%) while they increased in patients with disease progression (…

… C, Kaplan–Meier analysis for freedom from progression (left) and disease-… progression
from the end of treatment for all patients who experienced posttreatment disease progression by …

… However, initial disease control is then followed by a relatively short progression-free …
previously shown to play a critical role in lung cancer progression [54] and co-overexpression of …

… treated non-small-cell lung cancer, surgery-related mortality was higher (… lung cancer. Close
surveillance with yearly HRCT should be mandatory not only to monitor disease progression …

… disease.8, 9 These radiological manifestations can overlap with CT findings that are often
found in patients with lung cancer upon disease progression … during lung cancer progression …

… This was attributed to a crossover rate of more than 80% to the crizotinib arm at the point
of disease progression (PD). Median OS was NR (95% CI 45.8–NR) with crizotinib and was …

… Gastrointestinal stromal tumors have a unique biology with rapid disease progression … lung
cancer when gefitinib or erlotinib are stopped because of radiographic disease progression …

… lung cancer have sufficient accuracy to establish lung cancer in … specificity of identified volatiles
for lung cancer. This may be … in pulmonary disease has hampered the progress in sensor …

… risk of disease recurrence and thus guide treatment decisions for resectable lung cancer. …
validate such approaches and expand the utility of these rapidly progressing technologies. …

… cell lung cancer. These were the first five trials in patients with advanced nonsmall cell lung
cancer since we began using the evaluable disease … Time to disease progression calculated …